Literature DB >> 24966184

Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling.

Osama Abo Alrob1, Sowndramalingam Sankaralingam1, Cary Ma1, Cory S Wagg1, Natasha Fillmore1, Jagdip S Jaswal1, Michael N Sack2, Richard Lehner1, Mahesh P Gupta3, Evangelos D Michelakis1, Raj S Padwal1, David E Johnstone1, Arya M Sharma1, Gary D Lopaschuk4.   

Abstract

AIMS: Lysine acetylation is a novel post-translational pathway that regulates the activities of enzymes involved in both fatty acid and glucose metabolism. We examined whether lysine acetylation controls heart glucose and fatty acid oxidation in high-fat diet (HFD) obese and SIRT3 knockout (KO) mice. METHODS AND
RESULTS: C57BL/6 mice were placed on either a HFD (60% fat) or a low-fat diet (LFD; 4% fat) for 16 or 18 weeks. Cardiac fatty acid oxidation rates were significantly increased in HFD vs. LFD mice (845 ± 76 vs. 551 ± 87 nmol/g dry wt min, P < 0.05). Activities of the fatty acid oxidation enzymes, long-chain acyl-CoA dehydrogenase (LCAD), and β-hydroxyacyl-CoA dehydrogenase (β-HAD) were increased in hearts from HFD vs. LFD mice, and were associated with LCAD and β-HAD hyperacetylation. Cardiac protein hyperacetylation in HFD-fed mice was associated with a decrease in SIRT3 expression, while expression of the mitochondrial acetylase, general control of amino acid synthesis 5 (GCN5)-like 1 (GCN5L1), did not change. Interestingly, SIRT3 deletion in mice also led to an increase in cardiac fatty acid oxidation compared with wild-type (WT) mice (422 ± 29 vs. 291 ± 17 nmol/g dry wt min, P < 0.05). Cardiac lysine acetylation was increased in SIRT3 KO mice compared with WT mice, including increased acetylation and activity of LCAD and β-HAD. Although the HFD and SIRT3 deletion decreased glucose oxidation, pyruvate dehydrogenase acetylation was unaltered. However, the HFD did increase Akt acetylation, while decreasing its phosphorylation and activity.
CONCLUSION: We conclude that increased cardiac fatty acid oxidation in response to high-fat feeding is controlled, in part, via the down-regulation of SIRT3 and concomitant increased acetylation of mitochondrial β-oxidation enzymes. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Akt; B-hydroxyacyl CoA dehydrogenase; Glucose oxidation; Long-chain acyl-CoA dehydrogenase; Lysine acetylation; Obesity; Sirtuin 3

Mesh:

Substances:

Year:  2014        PMID: 24966184      PMCID: PMC4155471          DOI: 10.1093/cvr/cvu156

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  48 in total

Review 1.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

Review 3.  Myocardial substrate metabolism in the normal and failing heart.

Authors:  William C Stanley; Fabio A Recchia; Gary D Lopaschuk
Journal:  Physiol Rev       Date:  2005-07       Impact factor: 37.312

4.  Sirtuin 1 (SIRT1) deacetylase activity is not required for mitochondrial biogenesis or peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) deacetylation following endurance exercise.

Authors:  Andrew Philp; Ai Chen; Debin Lan; Gretchen A Meyer; Anne N Murphy; Amy E Knapp; I Mark Olfert; Carrie E McCurdy; George R Marcotte; Michael C Hogan; Keith Baar; Simon Schenk
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

5.  Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site.

Authors:  Sivakama S Bharathi; Yuxun Zhang; Al-Walid Mohsen; Radha Uppala; Manimalha Balasubramani; Emanuel Schreiber; Guy Uechi; Megan E Beck; Matthew J Rardin; Jerry Vockley; Eric Verdin; Bradford W Gibson; Matthew D Hirschey; Eric S Goetzman
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

6.  An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion.

Authors:  T C Lehman; D E Hale; A Bhala; C Thorpe
Journal:  Anal Biochem       Date:  1990-05-01       Impact factor: 3.365

7.  Chronic heart failure reduces Akt phosphorylation in human skeletal muscle: relationship to muscle size and function.

Authors:  Michael J Toth; Kimberly Ward; Jos van der Velden; Mark S Miller; Peter Vanburen; Martin M Lewinter; Philip A Ades
Journal:  J Appl Physiol (1985)       Date:  2010-12-30

8.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

Authors:  Joseph T Rodgers; Carlos Lerin; Wilhelm Haas; Steven P Gygi; Bruce M Spiegelman; Pere Puigserver
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

9.  Glucose homeostasis, obesity and diabetes.

Authors:  Gul Bano
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2013-03-17       Impact factor: 5.237

10.  Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity.

Authors:  Lydia W S Finley; Wilhelm Haas; Valérie Desquiret-Dumas; Douglas C Wallace; Vincent Procaccio; Steven P Gygi; Marcia C Haigis
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

View more
  88 in total

1.  Acetyl-L-carnitine increases mitochondrial protein acetylation in the aged rat heart.

Authors:  Janos Kerner; Elizabeth Yohannes; Kwangwon Lee; Ashraf Virmani; Aleardo Koverech; Claudio Cavazza; Mark R Chance; Charles Hoppel
Journal:  Mech Ageing Dev       Date:  2015-02-07       Impact factor: 5.432

Review 2.  Sirtuin 3, Endothelial Metabolic Reprogramming, and Heart Failure With Preserved Ejection Fraction.

Authors:  Heng Zeng; Jian-Xiong Chen
Journal:  J Cardiovasc Pharmacol       Date:  2019-10       Impact factor: 3.105

3.  Lysine Acetylation Activates Mitochondrial Aconitase in the Heart.

Authors:  Jolyn Fernandes; Alexis Weddle; Caroline S Kinter; Kenneth M Humphries; Timothy Mather; Luke I Szweda; Michael Kinter
Journal:  Biochemistry       Date:  2015-06-19       Impact factor: 3.162

Review 4.  Mitochondrial sirtuins in the heart.

Authors:  Heiko Bugger; Constantin N Witt; Christoph Bode
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

5.  NAD(H) in mitochondrial energy transduction: implications for health and disease.

Authors:  Matthew A Walker; Rong Tian
Journal:  Curr Opin Physiol       Date:  2018-04-11

6.  Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy.

Authors:  Hongyi Zhou; Xinnuo Lei; Yun Yan; Todd Lydic; Jie Li; Neal L Weintraub; Huabo Su; Weiqin Chen
Journal:  JCI Insight       Date:  2019-06-11

7.  Aspirin increases mitochondrial fatty acid oxidation.

Authors:  Radha Uppala; Brianne Dudiak; Megan E Beck; Sivakama S Bharathi; Yuxun Zhang; Donna B Stolz; Eric S Goetzman
Journal:  Biochem Biophys Res Commun       Date:  2016-11-14       Impact factor: 3.575

8.  Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model.

Authors:  Angelical S Martin; Dennis M Abraham; Kathleen A Hershberger; Dhaval P Bhatt; Lan Mao; Huaxia Cui; Juan Liu; Xiaojing Liu; Michael J Muehlbauer; Paul A Grimsrud; Jason W Locasale; R Mark Payne; Matthew D Hirschey
Journal:  JCI Insight       Date:  2017-07-20

Review 9.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

Review 10.  Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases.

Authors:  Alice E Kane; David A Sinclair
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.